Session Information

JOS Session

[JOS Oral: O11] Polypoidal Choroidal Vasculopathy
Go back
print
Day
Apr 04 (Fri)
Time
16:15 - 17:03
Room
Room 20 - Imperial Hotel 2F Kiku
Topic
[JOS Session] Retina, Vitreous
Chair/Coordinator
Chair)Takashi Kitaoka

O2-050 / 

[JOS Session] Retina, Vitreous

Change of vascular lesions in PCV after loading therapy of aflibercept

Tetsuya Yamagishi

Change of vascular lesions in PCV after loading therapy of aflibercept

O2-051 / 

[JOS Session] Retina, Vitreous

Effect of 3months of intravitreal aflibercept for PCV classified in two groups

Ryusaburo Mori

Effect of 3months of intravitreal aflibercept for PCV classified in two groups

O2-052 / 

[JOS Session] Retina, Vitreous

Aflibercept for polypoidal choroidal vasculopathy with good visual acuity

Masaaki Saito

Aflibercept for polypoidal choroidal vasculopathy with good visual acuity

O2-053 / 

[JOS Session] Retina, Vitreous

Responses to aflibercept therapy and choroidal vascular hyperpermeability in PCV

Hideki Koizumi

Responses to aflibercept therapy and choroidal vascular hyperpermeability in PCV

Go back